Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 5/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10745045 | 0.77 | KDM4E (0.52) | GPR3ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL28494462 | 0.77 | GPR3 (0.50) | GPR3ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL144440 | 0.76 | GPR3 (0.55) | GPR3ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL309376 | 0.76 | GPR3 (0.55) | GPR3ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL29434786 | 0.76 | GPR3 (0.55) | GPR3ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL1518983 | 0.76 | GPR3 (0.55) | GPR3ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL24665533 | 0.75 | NQO1 (0.35) | ALDH1A1MAPTKDM4ENPC1RAB9A | |
| Ammonia Solution, Strong SCHEMBL28459123 | 0.74 | GPR3 (0.52) | GPR3ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL19135547 | 0.74 | GPR3 (0.52) | GPR3ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL13511901 | 0.73 | GPR3 (0.50) | GPR3ALDH1A1MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106905312-B | Has a Hg-pair ratio2+Asymmetric perfluorocyclopentene compound continuously selective with Cys and preparation method and application thereof | 江西科技师范大学 | 2020-05-15 | — | — | CN | claimed |
| CN-106905312-A | With to Hg2+Continuously selective asymmetric perfluoro-cyclopentene compound and its preparation method and application with Cys | 江西科技师范大学 | 2017-06-30 | — | — | CN | claimed |
| WO-2025242650-A1 | SWITCHABLE ENCAPSULATED LUMINESCENT PIGMENTS | GIESECKE+DEVRIENT CURRENCY TECHNOLOGY GMBH (DE) | 2025-11-27 | — | — | WO | disclosed |
| WO-2022262310-A1 | METHOD FOR SYNTHESIZING BTBF AROMATIC AMINE DERIVATIVES | 广东阿格蕾雅光电材料有限公司 | 2022-12-22 | — | — | WO | disclosed |
| EP-4053124-A1 | FIVE-MEMBERED HETEROCYCLIC OXOCARBOXYLIC ACID COMPOUND AND MEDICAL USE THEREOF | Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) | 2022-09-07 | — | — | EP | disclosed |
| EP-4010328-A1 | 5-HETEROARYL-PYRIDIN-2-AMINE CONFOUNDS AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS | Domain Therapeutics (FR) | 2022-06-15 | — | — | EP | disclosed |
| WO-2021083060-A1 | FIVE-MEMBERED HETEROCYCLIC OXOCARBOXYLIC ACID COMPOUND AND MEDICAL USE THEREOF | 中国科学院上海药物研究所 | 2021-05-06 | — | — | WO | disclosed |
| CN-106905312-B | Has a Hg-pair ratio2+Asymmetric perfluorocyclopentene compound continuously selective with Cys and preparation method and application thereof | 江西科技师范大学 | 2020-05-15 | — | — | CN | disclosed |
| CN-106905312-A | With to Hg2+Continuously selective asymmetric perfluoro-cyclopentene compound and its preparation method and application with Cys | 江西科技师范大学 | 2017-06-30 | — | — | CN | disclosed |
| US-9090639-B2 | Cold menthol receptor-1 antagonists | JANSSEN PHARMACEUTICA N.V. (BE) | 2015-07-28 | — | — | US | disclosed |
| US-9090639-B2 | Cold menthol receptor-1 antagonists | JANSSEN PHARMACEUTICA N.V. (BE) | 2015-07-28 | — | — | US | disclosed |
| WO-2006107784-A1 | IMIDAZOPYRIDAZINE COMPOUNDS | ELI LILLY AND COMPANY (US) | 2006-10-12 | — | — | WO | disclosed |
| US-20060097225-A1 | Optical recording material | ASAHI GLASS COMPANY, LIMITED (JP) | 2006-05-11 | — | — | US | disclosed |
| US-20060094839-A1 | Methods of using heterocycle-amine ligands, compositions, complexes, and catalysts | SYMYX TECHNOLOGIES, INC. (US) | 2006-05-04 | — | — | US | disclosed |
| US-20060094867-A1 | Heterocycle-amine ligands, compositions, complexes, and catalysts | SYMYX TECHNOLOGIES, INC. (US) | 2006-05-04 | — | — | US | disclosed |
| WO-2006036748-A2 | HETEROCYCLE-AMINE LIGANDS, COMPOSITIONS, COMPLEXES, AND CATALYSTS, AND METHODS OF MAKING AND USING THE SAME | SYMYX TECHNOLOGIES, INC. (US) | 2006-04-06 | — | — | WO | disclosed |
| EP-1637573-A1 | OPTICAL RECORDING MATERIAL | ASAHI GLASS COMPANY LTD. (JP) | 2006-03-22 | — | — | EP | disclosed |
| EP-0217530-B1 | DIHYDROPYRIDINES | ELI LILLY AND COMPANY (US) | 1990-10-31 | — | — | EP | disclosed |
| US-4659717-A | CAUSING VASODILATION | ELI LILLY AND COMPANY (US) | 1987-04-21 | — | — | US | disclosed |
| EP-0217530-A1 | Dihydropyridines | ELI LILLY AND COMPANY (US) | 1987-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094867-A1 | Heterocycle-amine ligands, compositions, complexes, and catalysts | PCNA, MYB, PNMT | GPR3 3110/4885ALDH1A1 2956/4885MAPT 1356/4885 |
| US-20060094839-A1 | Methods of using heterocycle-amine ligands, compositions, complexes, and catalysts | PCNA, PPOX, ODC1 | GPR3 3872/4885ALDH1A1 2397/4885MAPT 1597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.